Use of a Party’s Own Study Data. BMS may use and analyze the BMS Study Data for any purpose without obligation or accounting to the Recipient, who shall hold the BMS Study Data in confidence pursuant to this Agreement. The Recipient may use and analyze the Recipient Study Data for any purpose without obligation or accounting to BMS, who shall hold the Recipient Study Data in confidence pursuant to this Agreement.
Appears in 7 contracts
Samples: Collaboration and Supply Agreement (Replimune Group, Inc.), Trial Collaboration and Supply Agreement (Idera Pharmaceuticals, Inc.), Clinical Trial Collaboration and Supply Agreement (Mirati Therapeutics, Inc.)
Use of a Party’s Own Study Data. BMS may use use, analyze and analyze disclose to Third Parties the BMS Study Data for any purpose without obligation or accounting to Compugen. Compugen may use, analyze and disclose to Third Parties the Recipient, who shall hold the BMS Study Data in confidence pursuant to this Agreement. The Recipient may use and analyze the Recipient Compugen Study Data for any purpose without obligation or accounting to BMS, who shall hold the Recipient Study Data in confidence pursuant to this Agreement.
Appears in 1 contract
Use of a Party’s Own Study Data. BMS may use and analyze the BMS Study Data for any purpose without obligation or accounting to the Recipient, who shall hold the BMS Study Data in confidence pursuant to this AgreementExelixis. The Recipient Exelixis may use and analyze the Recipient Exelixis Study Data for any purpose without obligation or accounting to BMS, who shall hold the Recipient Study Data in confidence pursuant to this Agreement.
Appears in 1 contract
